文献速递头颈与中枢神经肿瘤

IFNγ对CAR T细胞介导的髓系激活和内源性免疫诱导至关重要

IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity.
PubMed 文献 · Cancer Discov · 2021-04-09

该研究在小鼠同基因胶质母细胞瘤(GBM)模型及人GBM患者样本中揭示,CAR T细胞通过IFNγ信号激活瘤内髓系细胞并诱导内源性T细胞记忆应答,且宿主免疫细胞对IFNγ的响应性是重塑肿瘤免疫微环境的关键。人IL13Rα2-CAR T细胞同样经IFNγ信号激活患者来源的内源性T细胞和单核/巨噬细胞,并在一例应答患者中诱导肿瘤特异性T细胞应答。

要点

  • CAR T细胞产生的IFNγ及宿主免疫细胞对IFNγ的响应性对重塑肿瘤免疫微环境至关重要。
  • CAR T细胞可激活瘤内髓系细胞并诱导内源性T细胞记忆应答,形成正向循环。
  • 人IL13Rα2-CAR T细胞经IFNγ信号激活患者内源性T细胞和单核/巨噬细胞。

核心结论

  • IFNγ信号对GBM中有效的CAR T细胞治疗发挥关键作用。
  • CAR T细胞可激活驻留髓系细胞群并促进内源性T细胞免疫,提示宿主先天和适应性免疫对实体瘤CAR T治疗的重要性。

研究设计与样本

  • 研究采用小鼠同基因胶质母细胞瘤(GBM)模型及人GBM患者来源样本进行实验。

主要发现

  • CAR T细胞治疗小鼠同基因GBM可激活瘤内髓系细胞并诱导内源性T细胞记忆应答,伴随CAR T细胞应答的正向循环扩增。
  • CAR T细胞产生IFNγ及宿主免疫细胞对IFNγ的响应性对肿瘤免疫景观重塑、促进更活化且抑制性更低的肿瘤微环境至关重要。
  • 人IL13Rα2-CAR T细胞通过IFNγ信号激活患者来源的内源性T细胞和单核/巨噬细胞,并在一例应答的GBM患者中诱导肿瘤特异性T细胞应答。

临床怎么用

  • 上述发现提示CAR T细胞治疗可塑造肿瘤微环境,为激发内源性抗肿瘤免疫创造条件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chimeric antigen receptor (CAR) T cells mediate potent antigen-specific antitumor activity; however, their indirect effects on the endogenous immune system are not well characterized. Remarkably, we demonstrate that CAR T-cell treatment of mouse syngeneic glioblastoma (GBM) activates intratumoral myeloid cells and induces endogenous T-cell memory responses coupled with feed-forward propagation of CAR T-cell responses. IFNγ production by CAR T cells and IFNγ responsiveness of host immune cells are critical for tumor immune landscape remodeling to promote a more activated and less suppressive tumor microenvironment. The clinical relevance of these observations is supported by studies showing that human IL13Rα2-CAR T cells activate patient-derived endogenous T cells and monocytes/macrophages through IFNγ signaling and induce the generation of tumor-specific T-cell responses in a responding patient with GBM. These studies establish that CAR T-cell therapy has the potential to shape the tumor microenvironment, creating a context permissible for eliciting endogenous antitumor immunity. SIGNIFICANCE: Our findings highlight the critical role of IFNγ signaling for a productive CAR T-cell therapy in GBM. We establish that CAR T cells can activate resident myeloid populations and promote endogenous T-cell immunity, emphasizing the importance of host innate and adaptive immunity for CAR T-cell therapy of solid tumors.This article is highlighted in the In This Issue feature, p. 2113.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Alizadeh D, Wong RA, Gholamin S, et al. IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity. Cancer Discov. 2021. PMID: 33837065. doi:10.1158/2159-8290.CD-20-1661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。